Terms: = Leukemia AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Diagnosis
74 results:
1. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
[No Abstract] [Full Text] [Related]
2. Childbirth rates in women with myeloproliferative neoplasms.
Landtblom AR; Andersson TM; Johansson ALV; Lundberg FE; Samuelsson J; Björkholm M; Hultcrantz M
Leukemia; 2024 May; 38(5):1081-1085. PubMed ID: 38461191
[TBL] [Abstract] [Full Text] [Related]
3. In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation.
Brunner A; Thalhammer-Thurner GC; Willenbacher W; Haun M; Zelger BG; Willenbacher E
Ann Hematol; 2024 Feb; 103(2):553-563. PubMed ID: 37951851
[TBL] [Abstract] [Full Text] [Related]
4. Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia.
Zhang Y; Wu Q; Yuan B; Huang Y; Jiang L; Liu F; Yan P; Jiang Y; Ye J; Jiang X
BMC Cancer; 2023 Oct; 23(1):1030. PubMed ID: 37875840
[TBL] [Abstract] [Full Text] [Related]
5. Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial.
Schrag D; Uno H; Rosovsky R; Rutherford C; Sanfilippo K; Villano JL; Drescher M; Jayaram N; Holmes C; Feldman L; Zattra O; Farrar-Muir H; Cronin C; Basch E; Weiss A; Connors JM;
JAMA; 2023 Jun; 329(22):1924-1933. PubMed ID: 37266947
[TBL] [Abstract] [Full Text] [Related]
6. Therapies for acute myeloid leukemia in patients ineligible for standard induction chemotherapy: a systematic review.
Heuser M; Fernandez C; Hauch O; Klibanov OM; Chaudhary T; Rives V
Future Oncol; 2023 Apr; 19(11):789-810. PubMed ID: 37170899
[TBL] [Abstract] [Full Text] [Related]
7. Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma.
El Hussein S; Medeiros LJ; Lyapichev KA; Fang H; Jelloul FZ; Fiskus W; Chen J; Wei P; Schlette E; Xu J; Li S; Kanagal-Shamanna R; Yang H; Tang Z; Thakral B; Loghavi S; Jain N; Thompson PA; Ferrajoli A; Wierda WG; Jabbour E; Patel KP; Dabaja BS; Bhalla KN; Khoury JD
Pathology; 2023 Jun; 55(4):514-524. PubMed ID: 36933995
[TBL] [Abstract] [Full Text] [Related]
8. Premature ovarian insufficiency in female adolescent and young adult survivors of non-gynecological cancers: a population-based cohort study.
Flatt SB; Baillargeon A; McClintock C; Pudwell J; Velez MP
Reprod Health; 2023 Jan; 20(1):4. PubMed ID: 36593491
[TBL] [Abstract] [Full Text] [Related]
9. Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases.
Wang Z; An J; Wang C
BMC Womens Health; 2022 Nov; 22(1):436. PubMed ID: 36345026
[TBL] [Abstract] [Full Text] [Related]
10. [Study of cytogenetics and molecular biology in typical and atypical immunophenotypic chronic lymphocytic leukemia].
Jin HM; Qiao C; Zhao SS; Qiu HR; Chen X; Yang H; Zhu LY; Li JY; Wu YJ
Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):469-474. PubMed ID: 35968589
[No Abstract] [Full Text] [Related]
11. Genetic counseling and carrier screening in candidates for gamete donation at a Portuguese center.
Soares CA; Tkachenko N; Vale-Fernandes E; Barreiro M; Abreu M; Reis CF; Soares G; Fortuna AM; Soares AR
JBRA Assist Reprod; 2023 Jun; 27(2):180-184. PubMed ID: 35916466
[TBL] [Abstract] [Full Text] [Related]
12. Association of TNF-α rs1800629 with Adult Acute B-Cell Lymphoblastic leukemia.
Abdalhabib EK; Algarni A; Saboor M; Alanazi F; Ibrahim IK; Alfeel AH; Alanazi AM; Alanazi AM; Alruwaili AM; Alanazi MH; Alshaikh NA
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886021
[TBL] [Abstract] [Full Text] [Related]
13. Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study.
Pagano L; Criscuolo M; Broccoli A; Piciocchi A; Varettoni M; Galli E; Anastasia A; Cantonetti M; Trentin L; Kovalchuk S; Orsucci L; Frustaci A; Spolzino A; Volpetti S; Annibali O; Storti S; Stelitano C; Marchesi F; Offidani M; Casadei B; Nizzoli ME; De Luca ML; Fianchi L; Motta M; Guarnera L; Simonetti E; Visentin A; Vassallo F; Deodato M; Sarlo C; Olivieri A; Falini B; Pulsoni A; Tiacci E; Zinzani PL
Blood Cancer J; 2022 Jul; 12(7):109. PubMed ID: 35853850
[TBL] [Abstract] [Full Text] [Related]
14. Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.
García-Sancho AM; Bellei M; López-Parra M; Gritti G; Cortés M; Novelli S; Panizo C; Petrucci L; Gutiérrez A; Dlouhy I; Bastos-Oreiro M; Sancho JM; Ramírez MJ; Moraleda JM; Carrillo E; Jiménez-Ubieto AI; Jarque I; Orsucci L; García-Torres E; Montalbán C; Dodero A; Arranz R; De Las Heras N; Pascual MJ; López-Jiménez J; Spina M; Re A; De Villambrosia SG; Bobillo S; Federico M; Caballero D
Haematologica; 2022 Nov; 107(11):2675-2684. PubMed ID: 35320921
[TBL] [Abstract] [Full Text] [Related]
15. Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network.
Schäfer V; White HE; Gerrard G; Möbius S; Saussele S; Franke GN; Mahon FX; Talmaci R; Colomer D; Soverini S; Machova Polakova K; Cross NCP; Hochhaus A; Ernst T
J Cancer Res Clin Oncol; 2021 Oct; 147(10):3081-3089. PubMed ID: 33677711
[TBL] [Abstract] [Full Text] [Related]
16. Development and validation of a novel circular RNA as an independent prognostic factor in acute myeloid leukemia.
Wang J; Pan J; Huang S; Li F; Huang J; Li X; Ling Q; Ye W; Wang Y; Yu W; Jin J
BMC Med; 2021 Feb; 19(1):28. PubMed ID: 33517886
[TBL] [Abstract] [Full Text] [Related]
17. A reduced panel of eight genes (ATM, SF3B1, NOTCH1, birc3, XPO1, MYD88, TNFAIP3, and TP53) as an estimator of the tumor mutational burden in chronic lymphocytic leukemia.
Chauzeix J; Pastoret C; Donaty L; Gachard N; Fest T; Feuillard J; Rizzo D
Int J Lab Hematol; 2021 Aug; 43(4):683-692. PubMed ID: 33325634
[TBL] [Abstract] [Full Text] [Related]
18. Hospitalization after Adolescent and Young Adult (AYA) Cancer: A Population-Based Study in Utah.
Anderson C; Kaddas HK; Ou JY; Ramsay JM; Trogdon JG; Kirchhoff AC; Nichols HB
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):336-342. PubMed ID: 31959598
[TBL] [Abstract] [Full Text] [Related]
19. The association of mediastinal mass in the formation of thrombi in pediatric patients with non-lymphoblastic lymphomas.
Gartrell J; Kaste SC; Sandlund JT; Flerlage J; Zhou Y; Cheng C; Estepp J; Metzger ML
Pediatr Blood Cancer; 2020 Feb; 67(2):e28057. PubMed ID: 31736198
[TBL] [Abstract] [Full Text] [Related]
20. Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemia.
Huang YJ; Kuo MC; Chang H; Wang PN; Wu JH; Huang YM; Ma MC; Tang TC; Kuo CY; Shih LY
Br J Haematol; 2019 Oct; 187(1):82-92. PubMed ID: 31230372
[TBL] [Abstract] [Full Text] [Related]
[Next]
